22nd Century Group, Inc. – [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. RESEARCH FUNDING AGREEMENT BETWEEN THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA AND 22nd CENTURY LIMITED, LLC (March 8th, 2017)
This Research Funding Agreement is entered into as of December 14, 2016 (the "Agreement"), by and between The Rector and Visitors of the University of Virginia, a not-for-profit Virginia educational institution of the Commonwealth of Virginia located at 1001 North Emmet Street, Charlottesville, Virginia 22903 ("University"), and 22nd Century Limited, LLC, a for-profit Delaware limited liability company with its principal place of business at 9530 Main Street, Clarence, New York 14031 ("Sponsor"), for the purposes as hereinafter set forth.
22nd Century Group, Inc. – Research License and Commercial Option Agreement (January 30th, 2014)
This Research License and Commercial Option Agreement (this "Agreement") is entered into as of the 1st day of October, 2013 ("Effective Date") by and among 22nd Century Limited, LLC ("22nd Century") and 22nd Century Group, Inc. ("22nd Century Group"), each with its corporate headquarters at 9530 Main Street, Clarence, New York 14031, United States of America, and British American Tobacco (Investments) Limited ("BAT"), Reg. No. 00074974, with its registered office at Globe House, 1 Water Street, London WC2R 3LA, United Kingdom.